Answers are grounded in this paper and cite their sources.
Case report reveals subtype change in HER2-positive metaplastic breast cancer after anti-HER2 therapy, highlighting tumor heterogeneity implications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
KIHARA et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: